Greenwich LifeSciences, Inc. (GLSI)
24.06
-0.87
(-3.49%)
USD |
NASDAQ |
Feb 20, 16:00
24.19
+0.13
(+0.54%)
After-Hours: 20:00
Greenwich LifeSciences Market Cap : 333.34M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| 60 Degrees Pharmaceuticals, Inc. | 3.939M |
| Abbott Laboratories | 195.12B |
| Bristol Myers Squibb Co. | 123.53B |
| Janux Therapeutics, Inc. | 786.73M |
| Moderna, Inc. | 19.49B |
Market Cap Related Metrics
| PEG Ratio | -0.2042 |
| Price to Book Value | 152.56 |
| Price | 24.06 |
| Earnings Yield | -6.09% |
| PEGY Ratio | -0.2042 |